TP53 and breast carcinoma: found that circFOXO3 can interact with proteins to form a ternary complex (circFOXO3-MDM2-p53) and then promote MDM2-induced p53 ubiquitin degradation to prevent the ubiquitination of FOXO3 and increasing its synthesis in breast cancer cell lines (90).